Pharmiwebcom

16/07/2025

Recruiting in Life Sciences?
You need to read our latest FREE Report!

Download for FREE here: https://buff.ly/hIZyYiO

12/06/2025

RFK Jr. Names New CDC Vaccine Advisors Days After ‘Clean Sweep’

The eight new committee members replace the 17 Kennedy removed earlier this week. In “repopulating” the committee, the HHS Secretary fulfilled the fears of some analysts, naming scientists who appear to reflect his anti-vaccine views.

28/05/2025

Join 80+ industry experts at the much-anticipated 2nd Structure-Based Drug Design Summit this June.

This unmissable meeting will bring together leaders across structural biology, medicinal chemistry, and computational design such as Sanofi, AbbVie, Pfizer and AstraZeneca to accelerate early drug discovery.

Over three days, expert-led sessions will reveal how leading scientists leverage Cryo-EM, NMR, X-ray crystallography, and AI to tackle high-value targets and advance rational drug design for small molecules, peptides, biologics, and vaccines.

Find out more - https://ter.li/4tqnuj

20/05/2025

Search 1,748 Pharma & Life Science Jobs - https://bit.ly/3YRAIsj

- Clinical Research (569) - https://bit.ly/3F2x1t7
- Sales / Commercial (233) - https://bit.ly/3ZnNBKK
- Data Management / Statistics (119) - https://bit.ly/4mlO1uW
- Manufacturing (108) - https://bit.ly/4mvNkzx
- R & D (106) - https://bit.ly/43pLdEI
- Quality (90) - https://bit.ly/436W5sb
- Finance / Administration (76) - https://bit.ly/4kv27sh
- Medical Affairs (75) - https://bit.ly/4363cRC
- Healthcare (74) - https://bit.ly/44Mgc02
- Information Technology (71) - https://bit.ly/43BdWHD
- Operations (70) - https://bit.ly/43CVRZU
- Regulatory Affairs (66) - https://bit.ly/4dpOtEl
- Project Management (52) - https://bit.ly/45hw0b6
- HEOR (46) - https://bit.ly/3H186GW
- Marketing (44) - https://bit.ly/45hw0I8
- Medical Communications (31) - https://bit.ly/3FqdUZU
- HR / Recruitment / Training (20) - https://bit.ly/4k3HzqU

Register & Upload Your CV Now! https://bit.ly/45hw2zK
Follow us on LinkedIn: https://www.linkedin.com/company/pharmiweb-jobs/

16/05/2025

Search 1,690 Pharma & Life Science Jobs - https://bit.ly/4joX0ZX

- Clinical Research (567) - https://bit.ly/4k0Maua
- Sales / Commercial (220) - https://bit.ly/4jY4dRF
- Data Management / Statistics (125) - https://bit.ly/4dnnitV
- R & D (107) - https://bit.ly/45aiFRR
- Quality (96) - https://bit.ly/3ZkOdAN
- Manufacturing (94) - https://bit.ly/4dkzQCf
- Healthcare (83) - https://bit.ly/43vYzjH
- Medical Affairs (79) - https://bit.ly/43xIb2c
- Finance / Administration (73) - https://bit.ly/4dEf9lf
- Operations (66) - https://bit.ly/4jShon2
- Regulatory Affairs (63) - https://bit.ly/4j99jcB
- Information Technology (58) - https://bit.ly/4kgY0R7
- Project Management (44) - https://bit.ly/4jShtXS
- HEOR (34) - https://bit.ly/3Zg7mnu
- Marketing (29) - https://bit.ly/4dkTJt7
- Medical Communications (28) - https://bit.ly/4dle81a
- HR / Recruitment / Training (21) - https://bit.ly/4j2ItCL

Register & Upload Your CV Now! https://bit.ly/4dukCLi
Follow us on LinkedIn: https://www.linkedin.com/company/pharmiweb-jobs/

30/01/2024

Gilead and Arcus Announce Amended Collaboration and Equity Investment

Gilead Sciences, Inc. (Nasdaq: GILD) and Arcus Biosciences, Inc. (NYSE: RCUS) today announced an amendment to their collaboration agreement and a separate equity investment by Gilead of $320 million in Arcus common stock at $21.00 per share. The equity investment and collaboration amendment ...

29/01/2024

PharmiWeb Unveils New Branding in Celebration of 25th Anniversary

PharmiWeb, the leading global life science news and jobs portal, is excited to unveil its new branding in line with the company’s 25th anniversary celebrations. This fresh visual identity symbolises PharmiWeb’s commitment to continuous evolution, and to creating a standout user experience for .....

29/01/2024

Enhertu granted Priority Review in the US for patients with metastatic HER2-positive solid tumours

AstraZeneca and Daiichi Sankyo's supplemental Biologics License Application (sBLA) for Enhertu (trastuzumab deruxtecan) has been accepted and granted Priority Review in the US for the treatment of adult patients with unresectable or metastatic HER2-positive (immunohistochemistry [IHC] 3+) solid ...

26/01/2024

AbbVie Expands Biologics Manufacturing Capacity with a $223 Million Investment in Singapore Manufacturing Site

AbbVie (NYSE: ABBV) strengthened its manufacturing capabilities by breaking ground Thursday on a new US$223 million (S$301 million) expansion of its Singapore manufacturing facility. This new investment will add more than 100 jobs and new biologics manufacturing capacity to AbbVie's global ...

25/01/2024

According to Germany Trade & Invest (GTAI), constitutes the major European market and the fourth largest worldwide, with a pharmaceutical market that is growing at a faster rate than the German economy.

The country is home to more than 600 pharmaceutical companies, with the pharma industry employing around 140,000 people. In this article, we highlight the top 10 and companies in Germany as of 2023, based on their market capitalisation.

The country is home to more than 600 pharmaceutical companies, with the pharma industry employing around 140,000 people. In this article, we highlight the top 10 biotech and pharma companies in Germany as of 2023, based on their market capitalisation.

25/01/2024

New ICON survey highlights importance of combination therapies in future obesity treatment

ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced results from a recent industry survey of over 100 professionals engaged in obesity-related clinical research to measure industry opinions on trends within this therapeutic ...

24/01/2024

Bristol Myers Squibb Completes Acquisition of Mirati Therapeutics, Strengthening and Diversifying Oncology Portfolio

Bristol Myers Squibb (NYSE: BMY) today announced that it has successfully completed its acquisition of Mirati Therapeutics, Inc.® (“Mirati”). With the completion of the acquisition, Mirati shares have ceased trading on the NASDAQ Global Select Market and Mirati is now a wholly owned subsidiary ...